206 related articles for article (PubMed ID: 34179782)
21. Chemoenzymatic Synthesis of Glycosaminoglycans.
Zhang X; Lin L; Huang H; Linhardt RJ
Acc Chem Res; 2020 Feb; 53(2):335-346. PubMed ID: 31714740
[TBL] [Abstract][Full Text] [Related]
22. Chemoenzymatic design of heparan sulfate oligosaccharides.
Liu R; Xu Y; Chen M; Weïwer M; Zhou X; Bridges AS; DeAngelis PL; Zhang Q; Linhardt RJ; Liu J
J Biol Chem; 2010 Oct; 285(44):34240-9. PubMed ID: 20729556
[TBL] [Abstract][Full Text] [Related]
23. Synergestic interplay of uronic acid and sulfation composition of heparan sulfate on molecular recognition to activity.
Bhoge PR; Raigawali R; Mardhekar S; Anand S; Kikkeri R
Carbohydr Res; 2023 Oct; 532():108919. PubMed ID: 37557021
[TBL] [Abstract][Full Text] [Related]
24. Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains.
Kato M; Wang H; Bernfield M; Gallagher JT; Turnbull JE
J Biol Chem; 1994 Jul; 269(29):18881-90. PubMed ID: 8034644
[TBL] [Abstract][Full Text] [Related]
25. N-Acetylated domains in heparan sulfates revealed by a monoclonal antibody against the Escherichia coli K5 capsular polysaccharide. Distribution of the cognate epitope in normal human kidney and transplant kidney with chronic vascular rejection.
Born J; Jann K; Assmann KJ; Lindahl U; Berden JH
J Biol Chem; 1996 Sep; 271(37):22802-9. PubMed ID: 8798457
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in biotechnology for heparin and heparan sulfate analysis.
Qiao M; Lin L; Xia K; Li J; Zhang X; Linhardt RJ
Talanta; 2020 Nov; 219():121270. PubMed ID: 32887160
[TBL] [Abstract][Full Text] [Related]
27. Influence of saccharide modifications on heparin lyase III substrate specificities.
Wu J; Chopra P; Boons GJ; Zaia J
Glycobiology; 2022 Mar; 32(3):208-217. PubMed ID: 33822051
[TBL] [Abstract][Full Text] [Related]
28. Structural and substrate specificity analysis of 3-
Wander R; Kaminski AM; Wang Z; Stancanelli E; Xu Y; Pagadala V; Li J; Krahn JM; Pham TQ; Liu J; Pedersen LC
ACS Catal; 2021 Dec; 11(24):14956-14966. PubMed ID: 35223137
[TBL] [Abstract][Full Text] [Related]
29. Synthetic anticoagulant heparan sulfate attenuates liver ischemia reperfusion injury.
Arnold K; Xu Y; Liao YE; Cooley BC; Pawlinski R; Liu J
Sci Rep; 2020 Oct; 10(1):17187. PubMed ID: 33057098
[TBL] [Abstract][Full Text] [Related]
30. Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures.
Chen J; Jones CL; Liu J
Chem Biol; 2007 Sep; 14(9):986-93. PubMed ID: 17884631
[TBL] [Abstract][Full Text] [Related]
31. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
[TBL] [Abstract][Full Text] [Related]
32. Facile chemoenzymatic synthesis of unmodified anticoagulant ultra-low molecular weight heparin.
Zhang G; Yang K; Wang L; Cheng Y; Liu C
Org Biomol Chem; 2022 Nov; 20(42):8323-8330. PubMed ID: 36239281
[TBL] [Abstract][Full Text] [Related]
33. A new sequencing approach for N-unsubstituted heparin/heparan sulfate oligosaccharides.
Liang QT; Xiao XM; Lin JH; Wei Z
Glycobiology; 2015 Jul; 25(7):714-25. PubMed ID: 25677303
[TBL] [Abstract][Full Text] [Related]
34. Use of sulfated linked cyclitols as heparan sulfate mimetics to probe the heparin/heparan sulfate binding specificity of proteins.
Freeman C; Liu L; Banwell MG; Brown KJ; Bezos A; Ferro V; Parish CR
J Biol Chem; 2005 Mar; 280(10):8842-9. PubMed ID: 15632177
[TBL] [Abstract][Full Text] [Related]
35. Concise chemoenzymatic synthesis of heparan sulfate analogues as potent BACE-1 inhibitors.
Li J; Li J; Sun T; Cai C; Shao M; Yu G
Carbohydr Polym; 2019 Aug; 217():232-239. PubMed ID: 31079681
[TBL] [Abstract][Full Text] [Related]
36. GAG-ID: Heparan Sulfate (HS) and Heparin Glycosaminoglycan High-Throughput Identification Software.
Chiu Y; Huang R; Orlando R; Sharp JS
Mol Cell Proteomics; 2015 Jun; 14(6):1720-30. PubMed ID: 25887393
[TBL] [Abstract][Full Text] [Related]
37. Recombinant Heparin-New Opportunities.
Glass CA
Front Med (Lausanne); 2018; 5():341. PubMed ID: 30564580
[TBL] [Abstract][Full Text] [Related]
38. Preparation and characterization of partial de-O-sulfation of heparin oligosaccharide library.
Lin J; Zheng L; Liang Q; Jiang L; Wei Z
Carbohydr Res; 2021 Jan; 499():108226. PubMed ID: 33401230
[TBL] [Abstract][Full Text] [Related]
39. Developing a solid-phase method for the enzymatic synthesis of heparan sulfate and chondroitin sulfate backbones.
Stancanelli E; Liu W; Su G; Padagala V; Liu J
Glycobiology; 2024 Mar; 34(2):. PubMed ID: 37995272
[TBL] [Abstract][Full Text] [Related]
40. Interaction of thrombospondin-1 and heparan sulfate from endothelial cells. Structural requirements of heparan sulfate.
Feitsma K; Hausser H; Robenek H; Kresse H; Vischer P
J Biol Chem; 2000 Mar; 275(13):9396-402. PubMed ID: 10734084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
